Douglass Winthrop Advisors, LLC Bristol Myers Squibb CO Transaction History

Douglass Winthrop Advisors, LLC

$4.77 Billion
Q2 2024

A detailed history of Douglass Winthrop Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Douglass Winthrop Advisors, LLC holds 37,652 shares of BMY stock, worth $2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

37,652

Previous 42,016 10.39%

Holding current value

$2 Million

Previous $2.28 Million 31.39%

% of portfolio

0.03%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$40.25 - $52.99 $175,651 - $231,248	-4,364 Reduced 10.39%	37,652 $1.56 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $235,245 - $266,723	-4,903 Reduced 10.45%	42,016 $2.28 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $9,696 - $11,570	-200 Reduced 0.42%	46,919 $2.41 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $8,451 - $9,450	-146 Reduced 0.31%	47,119 $2.73 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $535,536 - $607,419	8,150 Added 20.84%	47,265 $3.28 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $39,855 - $47,194	-582 Reduced 1.47%	39,115 $2.81 Million
Q3 2022 Nov 15, 2022	SELL	$0.13 - $76.84 $130 - $76,840	-1,000 Reduced 2.46%	39,697 $2.82 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $36,310 - $39,990	-500 Reduced 1.21%	40,697 $3.13 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $4,426 - $5,307	-72 Reduced 0.17%	41,197 $3.01 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $23,168 - $27,008	-432 Reduced 1.04%	41,269 $2.57 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $256,383 - $300,320	4,333 Added 11.6%	41,701 $2.47 Million
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $96,951 - $105,579	1,566 Added 4.37%	37,368 $2.5 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $64,383 - $72,412	1,085 Added 3.13%	35,802 $2.26 Million
Q4 2020 Jan 27, 2021	SELL	$57.74 - $65.43 $43,478 - $49,268	-753 Reduced 2.12%	34,717 $2.15 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $289,906 - $321,254	-5,048 Reduced 12.46%	35,470 $2.14 Million
Q2 2020 Jul 17, 2020	BUY	$54.82 - $64.09 $40,073 - $46,849	731 Added 1.84%	40,518 $2.38 Million
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $172,608 - $250,839	-3,720 Reduced 8.55%	39,787 $2.22 Million
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $407,655 - $531,749	8,284 Added 23.52%	43,507 $2.79 Million
Q3 2019 Oct 08, 2019	SELL	$42.77 - $50.71 $18,305 - $21,703	-428 Reduced 1.2%	35,223 $1.79 Million
Q2 2019 Jul 10, 2019	SELL	$44.62 - $49.34 $178,926 - $197,853	-4,010 Reduced 10.11%	35,651 $1.62 Million
Q1 2019 Apr 09, 2019	SELL	$45.12 - $53.8 $372,240 - $443,850	-8,250 Reduced 17.22%	39,661 $1.89 Million
Q4 2018 Jan 16, 2019	BUY	$48.76 - $63.23 $509,346 - $660,500	10,446 Added 27.88%	47,911 $2.49 Million
Q3 2018 Oct 12, 2018	BUY	$55.19 - $62.25 $353,657 - $398,898	6,408 Added 20.63%	37,465 $2.33 Million
Q2 2018 Jul 24, 2018	SELL	$50.53 - $62.98 $120,766 - $150,522	-2,390 Reduced 7.15%	31,057 $1.72 Million
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $8,029 - $9,243	-134 Reduced 0.4%	33,447 $2.12 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $35,964 - $39,210	-600 Reduced 1.76%	33,581 $2.06 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $1.89 Million - $2.18 Million	34,181	34,181 $0

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.

Account

Douglass Winthrop Advisors, LLC Bristol Myers Squibb CO Transaction History